Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Acetate, Paroxetine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

58 API Suppliers, 27 USDMF, 15 CEP/COS, 8 JDMF, 11 EU WC, 13 KDMF, 12 NDC API, 25 Listed Suppliers, $ API Reference Price

INTERMEDIATES

12 Intermediate Suppliers

12 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

422 FDF Dossiers, 94 FDA Orange Book, 199 Europe, 59 Canada, 20 Australia, 23 South Africa, 27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 30MG BASE, TABLET;ORAL - EQ 40MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 12.5MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 25MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Evonik, 1 Rochem International Inc, 6 SPI Pharma, 14 DKSH, 5 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 28 BASF, 1 Clariant, 14 Corel Pharma Chem, 6 DFE Pharma, 1 Doshion Polyscience, 2 Finar, 12 Gangwal Chemicals, 10 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 26 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

78 Fillers, Diluents & Binders, 67 Coating Systems & Additives, 39 Controlled & Modified Release, 30 Solubilizers, 26 Film Formers & Plasticizers, 26 Direct Compression, 25 Thickeners and Stabilizers, 23 Granulation, 21 Disintegrants & Superdisintegrants, 19 Taste Masking, 18 Topical, 18 Parenteral, 17 Lubricants & Glidants, 14 Co-Processed Excipients, 9 Emulsifying Agents, 8 Chewable & Orodispersible Aids, 7 Rheology Modifiers, 6 API Stability Enhancers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 46 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 195 Regulatory FDF Prices, 8 Annual Reports

MARKET PLACE

12 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

62 Health Canada Patents

62 Health Canada Patents

REF. STANDARDS & IMPURITIES

8 EDQM, 8 USP, 4 JP, 18 Others

ANALYTICAL

4 BioAnalytical Methods, 1 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
28/03/2025	Assia Chemical Industries Ltd	Israel	Assia Chemical Industries Ltd.	223MF10002	Paroxetine hydrochloride hydrate "Teva"	2011-01-07	2011-11-17	Neot-Hovav Eco-Industrial Park, Emek Sara P. O. Box 2049 Be'er Sheva 8412316, Israel
28/03/2025	Daito Pharmaceutical	Japan	Daito Co., Ltd.	222MF10257	Paroxetine hydrochloride hydrate	2010-11-18	2011-11-07	326 Yokamachi, Toyama City, Toyama Prefecture

Acetate, Paroxetine

Acetate, Paroxetine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

58 API Suppliers

27 USDMF

15 CEP/COS

8 JDMF

11 EU WC

13 KDMF

12 NDC API

25 Listed Suppliers

$ API Reference Price

INTERMEDIATES

12 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

422 FDF Dossiers

94 FDA Orange Book

199 Europe

59 Canada

20 Australia

23 South Africa

27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE

TABLET;ORAL - EQ 20MG BASE

TABLET;ORAL - EQ 30MG BASE

TABLET;ORAL - EQ 40MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 12.5MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 25MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Evonik

1 Rochem International Inc

6 SPI Pharma

14 DKSH

5 Faran Shimi Pharmaceutical

4 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

9 Nanjing Well Pharmaceutical

1 ACG Worldwide

7 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

28 BASF

1 Clariant

14 Corel Pharma Chem

6 DFE Pharma

1 Doshion Polyscience

2 Finar

12 Gangwal Chemicals

10 Ideal Cures Pvt Ltd

3 Ingredion Pharma Solutions

36 Kerry

3 Kima Chemical

6 Lonza Capsugel

12 Microlex e.U

1 Nanjing Bold Chemical

2 Nomisma Healthcare

2 Novo Excipients

3 Pharmatrans-Sanaq

6 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

26 Roquette

14 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

2 The Dow Chemical Company

1 Ulanqab Kema New Material

3 Valens Pharmachem

3 Vasa Pharmachem